Indeed, the studies evaluating syndecan-4 as a heart failure biomarker published so far include mostly Asians or Caucasian populations, and data from mixed, and afro-descendent populations, such as the one included in our study, cannot be found in the literature. Here, SDC4 is linked to heart failure.